MetLife Investment Management’s Innospec IOSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.2M | Buy |
14,712
+581
| +4% | +$46K | 0.01% | 1432 |
|
|
2026
Q1 | $1.03M | Sell |
14,131
-125
| -0.9% | -$9.73K | 0.01% | 1379 |
|
|
2025
Q4 | $1.09M | Sell |
14,256
-633
| -4% | -$47.8K | 0.01% | 1378 |
|
|
2025
Q3 | $1.15M | Hold |
14,889
| – | – | 0.01% | 1361 |
|
|
2025
Q2 | $1.25M | Buy |
14,889
+159
| +1% | +$13.9K | 0.01% | 1195 |
|
|
2025
Q1 | $1.4M | Sell |
14,730
-496
| -3% | -$52.5K | 0.01% | 1213 |
|
|
2024
Q4 | $1.68M | Buy |
15,226
+842
| +6% | +$96.4K | 0.01% | 1137 |
|
|
2024
Q3 | $1.63M | Hold |
14,384
| – | – | 0.01% | 1136 |
|
|
2024
Q2 | $1.78M | Buy |
14,384
+1,568
| +12% | +$196K | 0.01% | 1031 |
|
|
2024
Q1 | $1.65M | Sell |
12,816
-345
| -3% | -$41.9K | 0.01% | 1046 |
|
|
2023
Q4 | $1.62M | Hold |
13,161
| – | – | 0.01% | 1040 |
|
|
2023
Q3 | $1.35M | Hold |
13,161
| – | – | 0.01% | 1082 |
|
|
2023
Q2 | $1.32M | Hold |
13,161
| – | – | 0.01% | 1120 |
|
|
2023
Q1 | $1.35M | Hold |
13,161
| – | – | 0.01% | 1078 |
|
|
2022
Q4 | $1.35M | Hold |
13,161
| – | – | 0.01% | 1065 |
|
|
2022
Q3 | $1.13M | Hold |
13,161
| – | – | 0.01% | 1126 |
|
|
2022
Q2 | $1.26M | Hold |
13,161
| – | – | 0.01% | 1095 |
|
|
2022
Q1 | $1.22M | Buy |
13,161
+4,722
| +56% | +$447K | 0.01% | 1205 |
|
|
2021
Q4 | $762K | Hold |
8,439
| – | – | 0.01% | 1256 |
|
|
2021
Q3 | $711K | Sell |
8,439
-953
| -10% | -$85K | 0.01% | 1321 |
|
|
2021
Q2 | $851K | Hold |
9,392
| – | – | 0.01% | 1262 |
|
|
2021
Q1 | $964K | Hold |
9,392
| – | – | 0.01% | 1176 |
|
|
2020
Q4 | $852K | Sell |
9,392
-1,191
| -11% | -$92.3K | 0.01% | 1207 |
|
|
2020
Q3 | $670K | Hold |
10,583
| – | – | 0.01% | 1227 |
|
|
2020
Q2 | $818K | Hold |
10,583
| – | – | 0.01% | 1109 |
|
|
2020
Q1 | $735K | Hold |
10,583
| – | – | 0.01% | 1029 |
|
|
2019
Q4 | $1.09M | Hold |
10,583
| – | – | 0.01% | 1056 |
|
|
2019
Q3 | $943K | Hold |
10,583
| – | – | 0.01% | 1098 |
|
|
2019
Q2 | $966K | Sell |
10,583
-21,166
| -67% | -$1.78M | 0.01% | 1119 |
|
|
2019
Q1 | $2.65M | Buy |
31,749
+21,810
| +219% | +$1.63M | 0.01% | 1110 |
|
|
2018
Q4 | $614K | Sell |
9,939
-1,364
| -12% | -$93.8K | 0.01% | 1240 |
|
|
2018
Q3 | $868K | Hold |
11,303
| – | – | 0.01% | 1206 |
|
|
2018
Q2 | $865K | Hold |
11,303
| – | – | 0.01% | 1087 |
|
|
2018
Q1 | $775K | Hold |
11,303
| – | – | 0.01% | 1125 |
|
|
2017
Q4 | $798K | Buy |
+11,303
| New | +$753K | 0.01% | 1135 |
|
Other funds holding IOSP
MetLife Investment Management's IOSP Position: Q2 2026 in Review
MetLife Investment Management increased its Innospec (IOSP) stake by 4.1% in Q2 2026, buying an estimated $46K and bringing the position to 14,712 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #1432.
MetLife Investment Management first reported a position in IOSP in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.65M in Q1 2019. 281 funds tracked by Wall St. Rank hold IOSP as of Q2 2026.
- MetLife Investment Management held 14,712 shares of Innospec worth $1.2M as of Q2 2026.
- MetLife Investment Management bought 581 Innospec shares in Q2 2026, an estimated $46K.
- Innospec made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1432 holding.
- MetLife Investment Management first reported a position in Innospec in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Innospec position peaked at $2.65M in Q1 2019.
- 281 funds tracked by Wall St. Rank held Innospec as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.